Bio & Science

Wave of Drug Recalls and Fatal Incidents Rock India's Pharmaceutical Market Decades of Accumulated Distrust, Structural Problems Remain Unresolved Quality Improvements Unlikely in the Near Term Despite Tougher Regulations Market skepticism toward I

GLP-1-Driven Shift in Food Consumption Patterns Global Food Companies Race to Develop Nutrition-Focused Products Economic Impact Extending to Productivity and GDP Glucagon-like peptide-1 (GLP-1

Expansion of AI-Driven R&D Automation Ushers in the Era of Personalized Therapies Paradigm Shift in Drug Development from Candidate Discovery to Manufacturing Regulatory Reforms and Massive State Investment Become China's Weapons for Global Market Expansion

China’s clean-energy scale has lowered costs while concentrating industrial power Rare-earth controls show how market dominance can become geopolitical leverage Managed rivalry can preserve low prices without accepting strategic dependence

Europe Struggles Under Near-104°F Heat as Daily Life Faces Mounting Disruptions Energy Markets, Labor Productivity, and Inflation Expected to Face Broad Economic Pressure Climateflation Emerges as a Global Risk, Deepening Central Bank Policy Dilemmas

U.S.

Eli Lilly consistently confirms therapeutic efficacy in clinical trials of retatrutide Triple-action GLP-1, GIP and glucagon mechanism maximizes weight-loss effect Side effects including gastrointestinal dysfunction remain clear, requiring further study and improvement in additional trials

Rising demand for solutions to post-weight-loss side effects Restaurant industry begins overhauling its strategies GLP-1 effects extending into behavioral change GLP-1-based obesity medications are reshaping the broader consumer economy far beyond th

Major countries including France and the UK incorporate GLP-1 therapies into public healthcare systems Obesity redefined as a chronic disease under state-managed healthcare frameworks Drug reimbursement expected to reduce patient costs and expand treatment access

Europe managed the energy crisis, but did not solve it Relief payments protected households, but did not build security The next shock requires more power, storage, and domestic capacity In 2024, the EU is still i

A Shock Even Greater Than 2022: One-Fifth of LNG Supply Vanishes South Korea and Japan Ease Coal Power Restrictions, Taiwan Restarts Coal-Fired Generation Short-Term Coal Expansion May Ultimately Accelerate Structural Energy Reform

Soaring popularity of obesity drugs drives sharp decline in restaurant spending Small-portion meals launched to target appetite-suppressed consumers Sales of products aimed at preventing side effects such as hair loss also climb

The Iran war has made fossil fuel dependence a direct economic risk for Asia Renewable energy competition is now central to growth, inflation control and energy security China will gain, but India can compete too

Japan’s hydrogen strategy is not just climate policy; it is a sovereignty bet Solar is cheaper today, but Japan fears dependence on China-led clean-tech supply chains The real task is to expand renewables while keeping hydrogen only for sectors where it can truly cut emissions

$11.75 Billion Organon Deal Marks Largest Acquisition in Indian Pharmaceutical History Preparing for a ‘Biosimilar Golden Age’ Amid Intensifying Global Competition More Personnel, More Clinical Trials and Streamlined Reviews Pose Threat to Korean Biotech

Aviation emissions are also a route-efficiency problem, not only a fuel problem Liberalisation can cut emissions per passenger, but it can increase total demand The best policy combines open routes with strict carbon rules

Beaten Back by Mounjaro, Wegovy Bets on an OpenAI Alliance Roche and Eli Lilly Bring Nvidia Supercomputers Online AI Upends the Drug Industry as Bio-AI Convergence Accelerates Global pharmaceutical companies are accelerating “AI alliances” th

The EU carbon border tax works like a green trade barrier for many non-EU firms It may help EU producers now, but that edge will not last Without technology transfer, it risks becoming protectionism, not fair climate policy

China’s energy rise is now a story of renewable energy security, not only emissions Its real advantage is not just hardware, but the education and training system behind it Countries that teach energy skills well will be less exposed to future oil and power shocks

Semaglutide patents expire in China and India A stream of generic drugs priced at one-eighth of the list price stands ready Broader access to obesity drugs begins in earnest Wegovy/Photo=Novo Nordisk